Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children Read more about Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS) Read more about Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer Read more about Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer
Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure Read more about Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure
HCV Group Evaluation and Treatment Uptake (HCV GET-UP) Intervention Read more about HCV Group Evaluation and Treatment Uptake (HCV GET-UP) Intervention
Conscious Sedation vs General Anesthesia in TAVR Patients Read more about Conscious Sedation vs General Anesthesia in TAVR Patients
Pasireotide in Hyperinsulinemic Hypoglycemia Read more about Pasireotide in Hyperinsulinemic Hypoglycemia
Bi-Level Positive Airway Ventilation for Acute Chest Syndrome Read more about Bi-Level Positive Airway Ventilation for Acute Chest Syndrome
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS Read more about A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting Read more about Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting